Q: What were some of your most satisfying successes of the past year, and why? I’ve had the privilege of representing clients in a number of the most prominent transactions globally over the past year, including Pfizer in its $43 billion acquisition of Seagen, the Special Transaction Committee of the Board of DISH Network in its $22 billion combination with EchoStar, Hess in its $60 billion acquisition by Chevron and Diamondback Energy in its $26 billion merger with Endeavor Energy Resources.
The Diamondback transaction, the largest ever acquisition of a private company in the oil and gas industry, raised a number of complex issues for the deal team to address. Among other things, we designed a bespoke transaction consideration adjustment structure to address the parties’ commercial goals of retaining flexibility to return cash to their respective equityholders over the course of a potentially lengthy timeline to closing.
